StonvexLoading…
StonvexStonvexStonvexCore line items from BAM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 |
|---|---|---|---|
Revenue | $3.94B | $3.38B | $3.14B |
Operating Income | $2.92B | $2.55B | $2.55B |
Net Income | $2.40B | $2.11B | $2.14B |
EPS (Diluted) | Not available | Not available | $1.13 |
Total Assets | $17.05B | $14.16B | $3.21B |
Total Liabilities | $6.74B | $2.97B | $1.12B |
Cash & Equivalents | $1.58B | $404.00M | $9.00M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available |
Shares Outstanding | Not available | Not available | 396.50M |